Zai Lab Ltd

Research Zai Lab Ltd (ZLAB) on Bullrun: market cap USD 2.94B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 2.94B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 457.18M-USD 175.50M-USD 158.89M58.3%-0.16USD 679.57MUSD 204.53MUSD 715.50M
FY2024USD 397.61M-USD 257.10M-USD 220.53M63.0%-0.26USD 449.67MUSD 131.71MUSD 840.90M
FY2023USD 266.72M-USD 334.60M-USD 205.39M64.1%-0.35USD 790.15MUSD 0USD 796.12M
FY2022USD 212.67M-USD 443.30M-USD 392.23M65.2%-0.46USD 1.01BUSD 20.39MUSD 1.05B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 2.94Bn/an/an/a
20252025-12-31USD 1.95Bn/an/an/a
20242024-12-31USD 2.82Bn/an/an/a
20232023-12-29USD 2.69Bn/an/an/a
20222022-12-30USD 3.01Bn/an/an/a
20212021-12-31USD 6.00Bn/an/an/a

About Zai Lab Ltd

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Zai Lab Ltd's market cap?

Zai Lab Ltd's market capitalization is USD 2.94B.

What does Zai Lab Ltd do?

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.